Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for June 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Cardio Exercise Safe, Beneficial in Rheumatoid Arthritis
WEDNESDAY, June 30 (HealthDay News) -- Cardiorespiratory aerobic exercise is safe for rheumatoid arthritis (RA) patients and leads to improved function and quality of life, though its effect is small, according to a meta-analysis published in the July issue of Arthritis Care & Research.
Doctors Agree Malpractice Fears Drive Overuse of Tests
MONDAY, June 28 (HealthDay News) -- A large majority of physicians agree that the practice of defensive medicine -- stemming from malpractice concerns -- is responsible for an overuse of medical tests and procedures, according to a research letter in the June 28 issue of the Archives of Internal Medicine.
Gut Bacteria Linked to Autoimmune Arthritis in Mice
WEDNESDAY, June 23 (HealthDay News) -- The introduction of gut bacteria into mice prone to developing arthritis and previously housed in germ-free conditions leads to rapid onset of the condition, according to research published online June 17 in Immunity.
Celecoxib Linked to Lower Rate of Gastrointestinal Events
THURSDAY, June 17 (HealthDay News) -- The cyclooxygenase (COX)-2 selective nonsteroidal anti-inflammatory drug (NSAID) celecoxib is associated with a lower risk of gastrointestinal adverse events than the NSAID diclofenac plus the proton pump inhibitor (PPI) omeprazole in patients with osteoarthritis or rheumatoid arthritis, according to a study published online June 17 in The Lancet.
Fatal Medication Errors Rise in July at Teaching Hospitals
TUESDAY, June 8 (HealthDay News) -- In July there is a significant increase in fatal medication errors at medical institutions, and this spike is at least partly due to the arrival of new medical residents, according to a study published online May 29 in the Journal of General Internal Medicine.
Risk of GI Bleeding Varies by NSAID Type, Dosage
WEDNESDAY, June 2 (HealthDay News) -- The risk of gastrointestinal (GI) complications due to nonsteroidal anti-inflammatory drug (NSAID) use varies by the specific drug used and by dosage, and those with a slow-release formulation or long half-life are associated with a greater risk, according to research published in the June issue of Arthritis & Rheumatism.
RA Patients and Physicians Differ on Disease Severity
WEDNESDAY, June 2 (HealthDay News) -- Nearly one-third of rheumatoid arthritis (RA) patients assess the severity of their disease differently than their rheumatologists do, with the disparity most pronounced for patients with higher depressive symptoms, according to a study in the June issue of Arthritis Care & Research.
Copyright © 2010 ScoutNews, LLC. All rights reserved.
|Previous: June 2010 Briefing - Pulmonology||Next: June 2010 Briefing - Surgery|
Reader comments on this article are listed below. Review our comments policy.